Safety and Efficacy of MAT9001(Omega-3-pentaenoic Acid) in Subjects With Triglycerides ≥500 mg/dL and <2000 mg/dL
Status:
Withdrawn
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
To determine the efficacy of MAT9001 compared to placebo in lowering fasting triglyceride
levels in subjects with very high fasting triglyceride levels ≥ 500 and < 2000 mg/dL.